. Reduced CSF p-Tau181 to Tau ratio is a biomarker for FTLD-TDP. Neurology. 2013 Nov 26;81(22):1945-52. Epub 2013 Oct 30 PubMed.

AlzBiomarker Database

Meta-Analysis

Curated Study Data

Biomarker
(Source)
Cohort
(N)
Measurement
Mean ± SD
Method;
Assay Name;
Manufacturer
Diagnostic
Criteria
tau-phospho
(CSF)
AD
(25)
66.2 ± 45.1
pg/mL
xMAP;
AlzBio3;
Innogenetics
McKhann et al., 1984
tau-phospho
(CSF)
CTRL-
CNC
(13)
35.5 ± 18.3
pg/mL
xMAP;
AlzBio3;
Innogenetics
tau-total
(CSF)
AD
(25)
116.4 ± 72
pg/mL
xMAP;
AlzBio3;
Innogenetics
McKhann et al., 1984
tau-total
(CSF)
CTRL-
CNC
(13)
49.2 ± 24.4
pg/mL
xMAP;
AlzBio3;
Innogenetics

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.